Marvel·Astonishing X-Men·#2·Independent·ID-2404337
| Grade | Census & Float Distribution | Copies / Slabs | Role | FMV | Sales | Total Value | Multiple |
|---|---|---|---|---|---|---|---|
| 9.8 | 75 of 183 slabs (41.0%) | 75 | SOV | $21.78 | 75 | $1,634 | (4.4x) |
| 9.6 | 54 of 183 slabs (29.5%) | 54 | — | — | — | (29.5% / 0.04%) | |
| 9.4 | 33 of 183 slabs (18.0%) | 33 | — | — | — | (18.0% / 0.02%) | |
| 9.2 | 14 of 183 slabs (7.7%) | 14 | $27.00 | 14 | $378.00 | (5.4x) | |
| 9.0 | 5 of 183 slabs (2.7%) | 5 | — | — | — | (2.7% / <0.01%) | |
| RAW | ~95,132 surviving raw (of ~136,164 printed) | 95,132 | RAW | $4.99 | — | $474,709 | (1.0x Base) |
Autonomous institutional strategies, financial equilibrium, scarcity modeling, and algorithmic risk profiling.
Market operates purely on organic buyer and seller auction discovery. Zero artificial price interventions or emergency liquidity halts on record.
Understand how physical sales, invested dollars, and liquidity friction divide across grades.
Completed market sales by grade
Relative market value allocation
Estimated execution friction
Bibliographic provenance, creator credits, historical significance, and multimedia documentation.
Joss Whedon
John Cassaday
John Cassaday
Laura Martin
Mike Marts
Home of Spider-Man, X-Men, Avengers, and the Marvel Cinematic Universe.
Outside the Marvel/DC duopoly. Often creator-owned with outsized cultural impact and far greater natural scarcity.
No returnable copies, no overprint buffer. True scarcity with potential for explosive growth on media adaptation news.
Independent publisher — outside the Marvel/DC duopoly. These issues often carry outsized cultural impact with far greater natural scarcity. No returnable copies, no overprint buffer.
Inspectable mathematical proof, blockchain/ledger provenance, data integrity validation, and asset taxonomy.
The recovery of third-party encapsulation and grading expenditures when an asset is acquired at a discount below the physical cost of replacement grading fees, shipping, and insurance.
Dr. Kavita Rao promotes a cure at a press conference which she claims would safely and irreversibly eliminate the mutant strain. The X-Men handle a hostage situation led by Ord. While Shadowcat phases many of the hostages to safety, the rest of the team charges in and attacks Ord and his mercenaries. However, Ord and his men are prepared for the attack, and Ord hold his own against five X-Men. However, Lockheed surprises Ord by attacking him with a blast of fire to the face and knocking him out of the window of the building. The X-Men make peace with news reporter and Beast first hears about the "cure". At the Xavier Institute, many of the students have mixed feelings about the announcement. Emma Frost and Logan think that the government would use this cure as an excuse to horde up the mutants and execute them. After the rest of the team leaves, Emma Frost tells Kitty that she is here because Emma requested her to re-join the team. Emma explains that she needs someone on the team she has not really fought alongside to watch her if she leads the team astray. Kitty replies that she still views Emma as the embodiment of evil, saying, "I don't have to 'watch you', Miss Frost. I can smell you." Beast infiltrates BeneTech Laboratories and asks Dr. Rao if he can have a sample of the cure to see if it actually works and is not just a hoax.
Each cover variant, retailer incentive, and subsequent printing represents an independent atomic tradeable instrument with unique supply elasticity, barcode registration, and secondary market demand.
Strict algorithmic segregation separating clean single-issue Cover A sales from multi-issue lot bundles, retailer exclusives, and foreign variants.